DCM Shriram Fine Chemicals: Aditi Dhar Sells Entire Stake via Off-Market Transfer

Aditi Dhar has completely divested her shareholding in DCM Shriram Fine Chemicals Ltd. through an off-market share sale to Tilak Dhar & Sons. The transaction represents a significant change in the promoter group's internal shareholding structure, with Dhar reducing her stake to zero.

Transaction Details

The divestment involved the complete sale of 255,452 equity shares to Tilak Dhar & Sons through an off-market transaction completed on March 30, 2026. The transaction was disclosed under Regulation 29(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

Parameter:	Details
Shares Sold:	255,452
Sale Method:	Off-Market Transfer
Transaction Date:	March 30, 2026
Percentage Sold:	0.29%
Buyer:	Tilak Dhar & Sons
Final Holding:	Zero

Shareholding Pattern Changes

Prior to the transaction, Dhar held 255,452 shares representing 0.29% of DCM Shriram Fine Chemicals' equity capital. Following the complete divestment, her shareholding has been reduced to zero, with all shares transferred to Tilak Dhar & Sons within the promoter group structure.

Holding Period:	Number of Shares	Percentage
Pre-Transaction:	255,452	0.29%
Shares Sold:	255,452	0.29%
Post-Transaction:	0	0.00%

Regulatory Compliance and Promoter Group Structure

The transaction maintains the overall promoter group shareholding at 50.11% of the company's total equity capital of 86,992,185 shares. The promoter group includes Alok Shriram Karta L. Bansi Dhar & Sons (HUF) with 13.83%, Mrs. Urvashi Tilakdhar & Family with 10.28%, and other family members maintaining their respective stakes.

The regulatory filing was signed by Tilak Dhar & Sons as the buyer, with the disclosure dated April 1, 2026, from New Delhi. DCM Shriram Fine Chemicals trades on both NSE and BSE exchanges, maintaining its listing status throughout the transaction.

Akshay Dhar has executed a significant share acquisition in DCM Shriram Fine Chemicals Ltd., filing the required disclosure under SEBI's Substantial Acquisition of Shares and Takeovers Regulations, 2011. The transaction, completed through an off-market transfer, represents a strategic increase in his equity position within the specialty chemicals company.

Transaction Overview

The share acquisition was executed under specific regulatory parameters that demonstrate compliance with SEBI guidelines:

Parameter:	Details
Shares Acquired:	252706
Transaction Value (%):	0.29% of total share capital
Transaction Mode:	Off-market transfer
Transaction Date:	March 30, 2026
Seller/Transferor:	Tilak Dhar & Sons
Regulatory Exemption:	10(1)(a)(i)

Shareholding Changes

The transaction resulted in a notable change in Dhar's ownership structure within DCM Shriram Fine Chemicals:

Holding Period:	Number of Shares	Percentage (%)
Before Acquisition:	1274060	1.46
Shares Acquired:	252706	0.29
After Acquisition:	1526766	1.76

The acquisition represents approximately a 20% increase in Dhar's absolute shareholding, while his percentage ownership increased from 1.46% to 1.76% of the company's total voting capital.

Regulatory Compliance Framework

The transaction was structured as a distribution of assets through partition of HUF (Hindu Undivided Family), which qualifies for exemption under SEBI regulations. Key compliance aspects include:

Compliance Aspect:	Details
Initial Disclosure Date:	March 21, 2026
Transaction Completion:	March 30, 2026
Regulation Applied:	10(6) - Exempted Acquisition Report
Exchange Listing:	NSE (Symbol: DSFCL) & BSE (Scrip: 544703)

Corporate Structure Impact

The share transfer occurred between related entities within the promoter group structure, specifically from Tilak Dhar & Sons to Akshay Dhar. This internal reorganization maintains the overall promoter group holding while redistributing ownership among family entities. The transaction was executed without any monetary consideration, being structured as an asset distribution through HUF partition.

DCM Shriram Fine Chemicals Ltd. continues to maintain its stable capital structure, with shares listed on both NSE and BSE exchanges. The company operates under ISIN code INE00FMO1015, and the transaction adheres to all regulatory disclosure requirements under SEBI's substantial acquisition framework.